<?xml version="1.0" ?>
<document id="23544012">
  <sentence id="23544012.s0" text="Common genetic variants contribute to the observed variation in breast cancer risk for mitotic cytokinesis mutation carriers; those known to date have all been found through population-based genome-wide association studies (GWAS).">
    <entity charOffset="71-77" id="23544012.s0.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="87-106" id="23544012.s0.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="23544012.s0.e0" e2="23544012.s0.e1" id="23544012.s0.p0" relation="true"/>
  </sentence>
  <sentence id="23544012.s1" text="DNA samples from 3,881 breast cancer affected and 4,330 unaffected mitotic cytokinesis mutation carriers from 47 studies belonging to the Consortium of Investigators of Modifiers of BRCA1/2 were genotyped and available for analysis.">
    <entity charOffset="30-36" id="23544012.s1.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-86" id="23544012.s1.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="23544012.s1.e0" e2="23544012.s1.e1" id="23544012.s1.p0" relation="true"/>
  </sentence>
  <sentence id="23544012.s2" text="We replicated previously reported breast cancer susceptibility alleles in these mitotic cytokinesis mutation carriers and for several regions (including FGFR2, cellular response to mechanical stimulus, CDKN2A/B, and skeletal system development) identified SNPs that have stronger evidence of association than those previously published.">
    <entity charOffset="41-47" id="23544012.s2.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="80-99" id="23544012.s2.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="160-200" id="23544012.s2.e2" ontology_id="GO_0071260" text="cellular response to mechanical stimulus" type="GO"/>
    <entity charOffset="216-243" id="23544012.s2.e3" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <pair e1="23544012.s2.e0" e2="23544012.s2.e1" id="23544012.s2.p0" relation="true"/>
    <pair e1="23544012.s2.e0" e2="23544012.s2.e2" id="23544012.s2.p1" relation="true"/>
    <pair e1="23544012.s2.e0" e2="23544012.s2.e3" id="23544012.s2.p2" relation="false"/>
  </sentence>
  <sentence id="23544012.s3" text="This SNP was not associated with breast cancer risk either in the general population or in double-strand break repair via homologous recombination mutation carriers.">
    <entity charOffset="40-46" id="23544012.s3.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="91-146" id="23544012.s3.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="23544012.s3.e0" e2="23544012.s3.e1" id="23544012.s3.p0" relation="true"/>
  </sentence>
  <sentence id="23544012.s4" text="The locus lies within a region containing negative regulation of transcription by RNA polymerase II, which encodes a transcriptional activation protein that interacts with several tumor suppressor genes.">
    <entity charOffset="42-99" id="23544012.s4.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="180-185" id="23544012.s4.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="23544012.s4.e0" e2="23544012.s4.e1" id="23544012.s4.p0" relation="true"/>
  </sentence>
</document>
